Stay updated with breaking news from Nasdaq vvos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 14,000 shares, a decrease of 84.0% from the December 31st total of 87,300 shares. Based on an average daily volume of 998,700 shares, […] ....
Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership. Profitability This table compares Vivos Therapeutics and […] ....
With this unprecedented FDA clearance, Vivos redefines what it means to have a truly non-invasive treatment for all levels of OSA severity, opening new. ....
Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and Bioventus (NYSE:BVS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership. Profitability This table compares Vivos Therapeutics and Bioventus’ […] ....
Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and Silk Road Medical (NASDAQ:SILK – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Valuation and Earnings This table compares […] ....